The National Center for Tumor Diseases Dresden (NCT/UCC) is a joint institution of the German Cancer Research Center (DKFZ), the Carl Gustav Carus Faculty of Medicine at TU Dresden, University Hospital Carl Gustav Carus Dresden and the Helmholtz-Zentrum Dresden-Rossendorf (HZDR). It combines interdisciplinary patient care with excellent cancer research under one roof.
NCT/UCC Dresden at a glance
We seek to build on the results of cancer research in a fast and targeted approach for the benefit of patients, developing findings further, testing them in clinical trials, and translating them into routine treatments. Our goal is personalized cancer medicine, with therapies tailored to the individual patient.
History of cancer research and treatment in Dresden
The University Cancer Center (UCC) Dresden is established as a multidisciplinary center for tumor treatment, cancer research and teaching.
The OncoRay - Center for Radiation Research in Oncology is one of six centers for innovation competence included in the Create Excellence - Foster Talents funding program of the Federal Ministry of Education and Research (BMBF).
Start of the Collaborative Research Center 655: "Cells into tissues: Stem cell and progenitor commitment and interactions during tissue formation".
The UCC is recognized as an "Oncological Center of Excellence" by Deutsche Krebshilfe (DKH). This title has been renewed with every subsequent assessment.
The first partner site of the DKFZ’s Cancer Information Service (KID) is established in Dresden.
OncoRay is recognized as a "National Center for Radiation Research in Oncology" jointly with the Heidelberg Institute for Radiation Oncology (HIRO).
Dresden becomes a partner in the German Cancer Consortium (DKTK).
Germany’s Federal Minister of Research announces that NCT Heidelberg will be joined by a second site in Dresden.
Work begins on establishing NCT/UCC Dresden.
In summer of 2019, the DKFZ establishes its first branch site in Dresden.
The new NCT/UCC building is opened.
The new NCT/UCC building is extended and the third floor is officially opened.
The NCT expands to comprise six sites.
- Currently more than 300 oncological clinical trials
Main research areas at NCT/UCC Dresden:
- Evidence-based guidelines for diagnostics, therapy and post-therapy
- Up to 19 interdisciplinary tumor boards weekly
- Core units and platforms
The directorate of the NCT/UCC Dresden
Tel.: +49 (0)351 458 2742
Fax: +49 (0)351 458 4395